Literature DB >> 27169586

Imported falciparum malaria in adults: host- and parasite-related factors associated with severity. The French prospective multicenter PALUREA cohort study.

Fabrice Bruneel1, Florence Tubach2,3,4, Jean-Paul Mira5, Sandrine Houze6, Sebastien Gibot7, Marie-Genevieve Huisse8, Bruno Megarbane9, Christophe Choquet10, Philippe Corne11, Eric Peytel12, Daniel Villers13, Christophe Camus14, Olivier Bouchaud15, Eric Caumes16, Pierre-Marie Girard17, Fabrice Simon18, Antoine Kalloumeh19, Carine Roy3,4, Remy Durand20, Jacques Le Bras6, Sophie Matheron21, Michel Wolff22.   

Abstract

PURPOSE: Prospective data on potential factors associated with severity of imported Plasmodium falciparum malaria are lacking. We evaluated whether several host- and parasite-related biomarkers may improve early severity evaluation.
METHODS: Prospective multicenter observational study comparing uncomplicated and severe imported falciparum malaria in adults conducted in France in 52 units, from 2007 to 2010. Association of several host- and parasite-related biomarkers with severity of malaria was tested using univariate and multivariate analyses.
RESULTS: Of 295 patients, 140 had uncomplicated malaria and 155 severe malaria (including very severe and less severe cases according to predefined criteria). Curative intravenous quinine treatment was used in 154/155 patients with severe malaria and atovaquone/proguanil in 74 % of patients with uncomplicated malaria. Hospital mortality was 5.2 % (8 patients), all in the severe malaria group. Among host-related biomarkers, CRP, procalcitonin, and sTREM-1 were significantly higher and albumin was significantly lower in severe versus uncomplicated malaria; only the last three biomarkers also differed significantly between the very and less severe malaria groups. Among parasite-related biomarkers, only plasma PfHRP2 was significantly higher in severe versus uncomplicated malaria and in very severe versus less severe malaria; parasitemia did not differ between very and less severe malaria. By multivariate analysis, only lower plasma albumin and higher sTREM-1 were associated with greater severity, with intermediate accuracies.
CONCLUSIONS: During imported malaria, the most useful biomarkers associated with severity seem to be plasma albumin and sTREM-1; and among parasite-related parameters, PfHRP2 was more strongly associated with severity than parasitemia was.

Entities:  

Keywords:  Biomarkers; Intensive care; Malaria; Parasitemia; PfHRP2; Quinine

Mesh:

Substances:

Year:  2016        PMID: 27169586     DOI: 10.1007/s00134-016-4356-x

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  33 in total

Review 1.  Severe falciparum malaria. World Health Organization, Communicable Diseases Cluster.

Authors: 
Journal:  Trans R Soc Trop Med Hyg       Date:  2000-04       Impact factor: 2.184

2.  The clinical spectrum of severe imported falciparum malaria in the intensive care unit: report of 188 cases in adults.

Authors:  Fabrice Bruneel; Laurent Hocqueloux; Corinne Alberti; Michel Wolff; Sylvie Chevret; Jean-Pierre Bédos; Rémy Durand; Jacques Le Bras; Bernard Régnier; François Vachon
Journal:  Am J Respir Crit Care Med       Date:  2002-10-31       Impact factor: 21.405

3.  Serum procalcitonin in uncomplicated falciparum malaria: a preliminary study.

Authors:  Bernard Uzzan; Arezki Izri; Rémy Durand; Michèle Deniau; Olivier Bouchaud; Gérard-Yves Perret
Journal:  Travel Med Infect Dis       Date:  2005-07-01       Impact factor: 6.211

4.  Intravenous Artesunate Reduces Parasite Clearance Time, Duration of Intensive Care, and Hospital Treatment in Patients With Severe Malaria in Europe: The TropNet Severe Malaria Study.

Authors:  Florian Kurth; Michel Develoux; Matthieu Mechain; Jan Clerinx; Spinello Antinori; Ida E Gjørup; Joaquím Gascon; Kristine Mørch; Emanuele Nicastri; Michael Ramharter; Alessandro Bartoloni; Leo Visser; Thierry Rolling; Philipp Zanger; Guido Calleri; Joaquín Salas-Coronas; Henrik Nielsen; Gudrun Just-Nübling; Andreas Neumayr; Anna Hachfeld; Matthias L Schmid; Pietro Antonini; Peter Pongratz; Peter Kern; José Saraiva da Cunha; Antoni Soriano-Arandes; Mirjam Schunk; Norbert Suttorp; Christoph Hatz; Thomas Zoller
Journal:  Clin Infect Dis       Date:  2015-07-17       Impact factor: 9.079

5.  CTLA-4 positive T cells in contrast to procalcitonin plasma levels discriminate between severe and uncomplicated Plasmodium falciparum malaria in Ghanaian children.

Authors:  Nele Braun; Yeboah Marfo; Christiane Von Gärtner; Gerd D Burchard; P F Zipfel; N Edmund N Browne; Bernhard Fleischer; Barbara M Bröker
Journal:  Trop Med Int Health       Date:  2003-11       Impact factor: 2.622

6.  Plasma concentrations of parasite histidine-rich protein 2 distinguish between retinopathy-positive and retinopathy-negative cerebral malaria in Malawian children.

Authors:  Karl B Seydel; Lindsay L Fox; Simon J Glover; Mathew J Reeves; Paul Pensulo; Alice Muiruri; Ashley Mpakiza; Malcolm E Molyneux; Terrie E Taylor
Journal:  J Infect Dis       Date:  2012-05-25       Impact factor: 7.759

7.  Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial.

Authors:  Arjen M Dondorp; Caterina I Fanello; Ilse C E Hendriksen; Ermelinda Gomes; Amir Seni; Kajal D Chhaganlal; Kalifa Bojang; Rasaq Olaosebikan; Nkechinyere Anunobi; Kathryn Maitland; Esther Kivaya; Tsiri Agbenyega; Samuel Blay Nguah; Jennifer Evans; Samwel Gesase; Catherine Kahabuka; George Mtove; Behzad Nadjm; Jacqueline Deen; Juliet Mwanga-Amumpaire; Margaret Nansumba; Corine Karema; Noella Umulisa; Aline Uwimana; Olugbenga A Mokuolu; Olanrewaju T Adedoyin; Wahab B R Johnson; Antoinette K Tshefu; Marie A Onyamboko; Tharisara Sakulthaew; Wirichada Pan Ngum; Kamolrat Silamut; Kasia Stepniewska; Charles J Woodrow; Delia Bethell; Bridget Wills; Martina Oneko; Tim E Peto; Lorenz von Seidlein; Nicholas P J Day; Nicholas J White
Journal:  Lancet       Date:  2010-11-07       Impact factor: 79.321

8.  Copeptin does not accurately predict disease severity in imported malaria.

Authors:  Marlies E van Wolfswinkel; Dennis A Hesselink; Ewout J Hoorn; Yolanda B de Rijke; Rob Koelewijn; Jaap J van Hellemond; Perry J J van Genderen
Journal:  Malar J       Date:  2012-01-05       Impact factor: 2.979

9.  Procalcitonin as a biomarker for severe Plasmodium falciparum disease: a critical appraisal of a semi-quantitative point-of-care test in a cohort of travellers with imported malaria.

Authors:  Dennis A Hesselink; Jan-Steven Burgerhart; Hanna Bosmans-Timmerarends; Pieter Petit; Perry J J van Genderen
Journal:  Malar J       Date:  2009-09-01       Impact factor: 2.979

10.  Procalcitonin serum levels in tertian malaria.

Authors:  Christoph Manegold; Stefan Schmiedel; Collins B Chiwakata; Manfred Dietrich
Journal:  Malar J       Date:  2003-10-16       Impact factor: 2.979

View more
  7 in total

1.  Severe malaria in Europe: an 8-year multi-centre observational study.

Authors:  Florian Kurth; Michel Develoux; Matthieu Mechain; Denis Malvy; Jan Clerinx; Spinello Antinori; Ida E Gjørup; Joaquím Gascon; Kristine Mørch; Emanuele Nicastri; Michael Ramharter; Alessandro Bartoloni; Leo Visser; Thierry Rolling; Philipp Zanger; Guido Calleri; Joaquín Salas-Coronas; Henrik Nielsen; Gudrun Just-Nübling; Andreas Neumayr; Anna Hachfeld; Matthias L Schmid; Pietro Antonini; Tilman Lingscheid; Peter Kern; Annette Kapaun; José Saraiva da Cunha; Peter Pongratz; Antoni Soriano-Arandes; Mirjam Schunk; Norbert Suttorp; Christoph Hatz; Thomas Zoller
Journal:  Malar J       Date:  2017-01-31       Impact factor: 2.979

2.  Severe imported malaria in an intensive care unit: A case series.

Authors:  Fatma Al Farsi; Juhi Chandwani; Asmaa S Mahdi; Eskild Petersen
Journal:  IDCases       Date:  2019-04-30

3.  Clinical sign and biomarker-based algorithm to identify bacterial pneumonia among outpatients with lower respiratory tract infection in Tanzania.

Authors:  Kevin C Kain; Noémie Boillat-Blanco; Sarika K L Hogendoorn; Loïc Lhopitallier; Melissa Richard-Greenblatt; Estelle Tenisch; Zainab Mbarack; Josephine Samaka; Tarsis Mlaganile; Aline Mamin; Blaise Genton; Laurent Kaiser; Valérie D'Acremont
Journal:  BMC Infect Dis       Date:  2022-01-06       Impact factor: 3.090

4.  C-reactive protein as an early biomarker for malaria infection and monitoring of malaria severity: a meta-analysis.

Authors:  Polrat Wilairatana; Praphassorn Mahannop; Thanita Tussato; I-Mee Hayeedoloh; Rachasak Boonhok; Wiyada Kwanhian Klangbud; Wanida Mala; Kwuntida Uthaisar Kotepui; Manas Kotepui
Journal:  Sci Rep       Date:  2021-11-11       Impact factor: 4.379

5.  Soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) and other inflammatory mediators in malaria by Plasmodium vivax during enteroparasites coinfection.

Authors:  Myrela Conceição Santos de Jesus; José Hugo Romão Barbosa; Rubens Alex de Oliveira Menezes; Margarete do Socorro Mendonça Gomes; Lays Gisele Santos Bomfim; Tamirys Simão Pimenta; Andrea Regina de Souza Baptista; Ricardo Luiz Dantas Machado; Tatiana Rodrigues de Moura; Luciane Moreno Storti-Melo
Journal:  PLoS One       Date:  2022-06-24       Impact factor: 3.752

Review 6.  Severe malaria.

Authors:  Nicholas J White
Journal:  Malar J       Date:  2022-10-06       Impact factor: 3.469

7.  Procalcitonin as a Candidate Biomarker for Malarial Infection and Severe Malaria: A Meta-Analysis.

Authors:  Aongart Mahittikorn; Kwuntida Uthaisar Kotepui; Wanida Mala; Polrat Wilairatana; Manas Kotepui
Journal:  Int J Environ Res Public Health       Date:  2022-09-09       Impact factor: 4.614

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.